OncoMed Pharmaceuticals Cash Flow

Health Care & Life Sciences » Biotechnology | OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.

2013

2014

2015

2016

2017

Net Income before Extraordinaries

26,071.00

50,010.00

85,407.00

103,102.00

39,062.00

Depreciation, Depletion & Amortization

1,378.00

1,430.00

1,643.00

1,764.00

1,710.00

Other Funds

887.00

6,067.00

10,766.00

11,131.00

9,414.00

Funds from Operations

34,137.00

32,182.00

72,998.00

90,207.00

27,938.00

Changes in Working Capital

178,681.00

52,329.00

2,140.00

53,271.00

57,032.00

Net Operating Cash Flow

144,544.00

84,511.00

75,138.00

36,936.00

84,970.00

Capital Expenditures

557.00

1,809.00

1,364.00

1,158.00

585.00

Sale of Fixed Assets & Businesses

30.00

Purchase/Sale of Investments

57,237.00

96,585.00

85,030.00

28,545.00

57,835.00

Net Investing Cash Flow

57,794.00

98,364.00

83,666.00

29,703.00

57,250.00

Net Financing Cash Flow

105,918.00

2,082.00

1,778.00

65,148.00

4,044.00

Net Change in Cash

192,668.00

180,793.00

10,306.00

1,491.00

23,676.00

Free Cash Flow

143,987.00

86,320.00

76,502.00

38,094.00

85,555.00

Deferred Taxes & Investment Tax Credit

10,331.00

Change in Capital Stock